In fact, it is not completely elucidated how BRAF or NRAS mutations contribute to the emergence of benign melanocytic nevi as they are also the most frequent mutated genes in melanoma, occurring in early stages of tumor progression [18]. The gene discussed is BRAF; the disease is melanoma.